HOOKIPA Pharma up on immunotherapies preclinical data

Hookipa Pharma

13/04/2022 16:18

** Shares of biopharma co  HOOK.O  rise 11.9% at $1.97
    ** Co says new preclinical data shows its immunotherapies
induce potent T cell responses in novel combinations and
significant tumor control  urn:newsml:reuters.com:*:nGNX3gPc4Z
    ** Results highlight potential of co's platform technology
in difficult-to-treat cancers and as backbone of potential
combination therapies for cancer patients - HOOK
    ** Stock down ~15% YTD, including session's move

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))